References
- Klugman K. Pneumococcal resistance to antibiotics. Clin Microbiol Reviews. 1990; 3, 171-96.
- Pankuch G, Spangler S, Jacobs M et al. Activity of penicillin-G, ampicillin, amoxicillin, amoxicillin/clavulanate, and cefotaxime against 189 penicillin-susceptible and resistant pneumococci by agar dilution and E-test. 7th European Congress of Clinical Microbiology and Infectious Diseases, Abs. 311, Vienna, 1995.
- Wise R, Andrews JM, Brenwald N. The in vitro activity of OPC-17116, a new 5-methyl substituted quinolone. J Antimicrob Chemother. 1993: 31; 497-504.
- Bauernfeind A. Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin, and ciprofloxacin. J Antimicrob Chemother 1997: 40; 639-51.
- Jorgensen JH, Howel AW, Maher LA. Quantitative antimicrobial susceptibility testing of Haemophilus influenzae and Streptococcus pneumoniae by using the: E-test. J Clin Microbiol. 1991: 29; 109-14
- NCCLS. Performance standards for antimicrobial susceptibility testing; Eight informational supplement. NCCLS Document M100-S8, Vol. 18, No. 1, 1998.
- Tugwell P, Dennis DT, Weinstein A et al. Laboratory evaluation in the diagnosis of Lyme disease. Ann Intern Med. 1997; 127: 1109-23.
- Reid MC, Schoen RT, Evans J, Rosenberg JC, Horwitz RI. The consequences of overdiagnosis and overtreatment of Lyme disease : an observational study. Ann Intern Med. 1998; 128: 354-62.
- American College of Physicians. Guidelines for laboratory evaluation in the diagnosis of Lyme disease. Ann Intern Med. 1997; 127: 1106-8.
- Bigaignon G, Tomasi JP, Goubau P et al. A clinical and sero-epidemiological study of 190 belgian patients suffering form Lyme borrellosis. Acta Clin Belg. 1989; 44: 174-81.
- Blaauw I, Nohlmans L, van den Bogaard T, van der Linden S. Diagnostic tools in Lyme borreliosis : clinical history compared with serology. J Clin Epidemiol. 1992; 45: 1229-36.